Feb. 5, 2025 — According to research published in the American Journal of Roentgenology (AJR), photon-counting detector CT (PCD CT) yielded meaningful attenuation increases for gadoxetate disodium at considerably lower doses than previously documented for CT of gadolinium-based contrast agents (GBCAs) —albeit too high for clinical use (approximately 8-times greater than clinical doses).

Feb. 5, 2025 — Results of a new randomized trial involving more than 105,000 women reveals that the use of artificial intelligence (AI) in mammography screening significantly increases cancer detection rates while reducing the workload for radiologists.

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging agent, said it has received positive feedback from its End of Phase II Meeting with the US Food and Drug Administration (FDA) for the development of 99mTc-maraciclatide as a diagnostic agent for use with single-photon emission computed tomography (SPECT-CT) for the visualization and diagnosis of superficial peritoneal endometriosis (SPE) in women aged 16 years of age and older.

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 new customers with its ClearRead solutions to clearly, confidently and quickly detect cardiothoracic diseases.

Feb. 3, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has entered into a partnership with the Society for Immunotherapy of Cancer (SITC). This collaboration will launch the "Lunit Research Program" for SITC members, granting access to Lunit SCOPE IO for quantitative immune phenotyping and tumor microenvironment (TME) analysis from H&E whole slide images (WSIs).

Feb. 3, 2025 — RapidAI has received FDA 510(k) clearance for Lumina 3D by RapidAI — an automated 3D imaging reconstruction solution designed to replace manual workflows with an AI-powered approach based on the latest groundbreaking AI technology advances.

eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such as the Ministry of Health and the Saskatchewan Health Authority in Canada. 

Yunu, a provider of clinical trial imaging workflow and data management solutions, has partnered with WCG, a global leader in clinical trial solutions, in support of WCG’s imaging services. WCG is one of the world’s largest clinical services organizations, providing solutions that directly impacted 93% of all FDA-approved therapeutics last year.

Jan. 30, 2025 – Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimer’s disease and other dementias. The new criteria expand PET imaging guidance to include tau PET, incorporate updated information, and provide specific guidance to enhance diagnostic precision, treatment decisions, and patient care.

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Voluson Expert Series ultrasound systems. Voluson Expert 22, 20 and 18 combine high resolution image quality with advanced ultrasound technology and an ergonomic design for efficient workflow and a world-class user experience. The Voluson Expert Series integrates artificial intelligence (AI)-powered features and automation tools to help drive imaging performance and efficiencies in women’s healthcare.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now